Titan Pharmaceuticals Stock Net Income
| TTNPDelisted Stock | USD 4.61 0.00 0.00% |
Titan Pharmaceuticals' fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting Titan Stock price.
Titan |
Titan Pharmaceuticals Company Net Income Analysis
Titan Pharmaceuticals' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Titan Pharmaceuticals Net Income | (4.71 M) |
Most of Titan Pharmaceuticals' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Titan Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Titan Pharmaceuticals reported net income of (4.71 Million). This is 101.38% lower than that of the Pharmaceuticals sector and 106.72% lower than that of the Health Care industry. The net income for all United States stocks is 100.82% higher than that of the company.
Titan Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Titan Pharmaceuticals' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Titan Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Titan Pharmaceuticals by comparing valuation metrics of similar companies.Titan Pharmaceuticals is currently under evaluation in net income category among its peers.
Titan Fundamentals
| Return On Equity | -0.83 | |||
| Return On Asset | -0.44 | |||
| Current Valuation | 7.38 K | |||
| Shares Outstanding | 1.33 M | |||
| Shares Owned By Insiders | 8.94 % | |||
| Shares Owned By Institutions | 0.64 % | |||
| Number Of Shares Shorted | 35.4 K | |||
| Price To Earning | (3.60) X | |||
| Price To Book | 2.20 X | |||
| Price To Sales | 3,440 X | |||
| Gross Profit | (4.37 M) | |||
| EBITDA | (4.7 M) | |||
| Net Income | (4.71 M) | |||
| Cash And Equivalents | 6.42 M | |||
| Cash Per Share | 0.44 X | |||
| Total Debt | 483 K | |||
| Debt To Equity | 0.04 % | |||
| Current Ratio | 3.06 X | |||
| Book Value Per Share | 2.10 X | |||
| Cash Flow From Operations | (3.88 M) | |||
| Short Ratio | 0.41 X | |||
| Earnings Per Share | (2.92) X | |||
| Target Price | 7.0 | |||
| Number Of Employees | 10 | |||
| Beta | 1.38 | |||
| Market Capitalization | 6.13 M | |||
| Total Asset | 2.92 M | |||
| Retained Earnings | (396.54 M) | |||
| Working Capital | 2.44 M | |||
| Current Asset | 12.24 M | |||
| Current Liabilities | 4.85 M | |||
| Net Asset | 2.92 M |
About Titan Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Titan Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Titan Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Titan Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Titan Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Titan Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Titan Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Titan Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Titan Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Titan Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Titan Pharmaceuticals to buy it.
The correlation of Titan Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Titan Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Titan Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Titan Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Titan Stock
If you are still planning to invest in Titan Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Titan Pharmaceuticals' history and understand the potential risks before investing.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |